Ocular Therapeutix, Inc. - Common Stock — 분기별 현금 흐름 (NASDAQ:OCUL) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 457.94 M405.92 M451.33 M410.88 M808.06 M732.53 M 총 부채 142.59 M139.99 M145.42 M152.65 M153.75 M150.96 M 자본금 총액 315.34 M265.93 M305.92 M258.23 M654.31 M581.57 M 총 부채 및 주주자본 457.94 M405.92 M451.33 M410.88 M808.06 M732.53 M 총부채 68.5 M69.2 M69.91 M70.62 M71.34 M72.06 M 순부채 -323.6 M-280.48 M-321.23 M-274.15 M-665.72 M-594.64 M

뉴스

Ocular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates

Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?

EyePoint: The 'Pre-Readout' Surge Is Hiding A Commercial Reality Check (NASDAQ:EYPT)

Ocular Therapeutix, Inc. (OCUL) Presents at 49th Annual Meeting of the Macula Society - Slideshow (NASDAQ:OCUL) 2026-03-03

Ocular Therapeutix, wAMD 데이터에 목표 주가 상향 – Clear Street

Clear Street raises Ocular Therapeutix price target on wAMD data

Palantir, United Tech among market cap stock movers on Monday

오큘라 테라퓨틱스, TD 코웬 컨퍼런스: AXPAXLI 전략적 통찰

Ocular Therapeutix at TD Cowen Conference: Strategic Insights on AXPAXLI

윌리엄 블레어, Ocular Therapeutix에 대한 투자의견 재확인

William Blair reiterates Ocular Therapeutix stock rating on trial data

Ocular Therapeutix, CSO Heier, 주식 2.5만 달러 매도